On December 12, 2017 Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, reported that it will report financial results for its fiscal fourth quarter and year-ended September 30, 2017 prior to market open on Friday, December 15, 2017 (Press release, Ohr Pharmaceutical, DEC 12, 2017, View Source [SID1234522583]). The Company will also hold a live investor conference call and webcast at 8:30am Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call & Webcast
Friday, December 15 @ 8:30am Eastern Time
Domestic: 877-407-0789
International: 201-689-8562
Conference ID: 13674508
Webcast: View Source

Replays – Available through December 22, 2017
Domestic: 844-512-2921
International: 412-317-6671
Conference ID: 13674508